Invest in Biotechnology With Biotech ETFs

biotechnology etfs

We are definitely in the age of technological advancement. Every day new technology is being introduced at a rapid pace. And this does not only include gadgets and gizmos but biotechnology as well. The more we learn about technology and engineering the more we can apply it to both material items as well as human biology.

Whether you agree or not, is your right as an investor. And as an investor, you can take your opinion and turn it into an investing opportunity. Do you think the biotechnology is up-and-coming sector or maybe you are more bearish and think the advancements are overrated? Either way, you can take advantage of selling or buying a biotechnology industry ETF.

You can also utilize biotechnology ETFs in your investing strategy to diversify a portfolio or hedge any biotechnology risk you may have with other investments.

There are other ways to invest in the biotechnology sector besides ETFs. Like trying to select specific stocks involved with biotechnology. Or you can target a biotechnology index, but that could involve a lot of transactions and price-chasing in order to gain exposure to the biotechnology industry as a whole.

However, if you are looking to target the sector, consider including biotech ETFs in your investment strategy. With one transaction, you can gain exposure to the industry via a mini-portfolio focusing on biotechnology equities.

Biotechnology ETF List

And not only do you get instant exposure to the sector, but you get many of the other advantages that come with trading ETFs as well — especially the tax benefits. And ETFs can also help you save money. So if this is all sounds like a plan to you, then it may be time to consider some biotechnology funds.

BBH - Market Vectors Biotech ETF

BBH targets eighteen companies involved in the biotech sector. Some of the top holdings include Amgen Inc (AMGN), Gilead Sciences (GILD), and Biogen (BIIB)

BIB - Ultra NASDAQ Biotechnology ETF

This fund tracks the NASDAQ Biotechnology Index and seeks a 2x leveraged daily return on the underlying index. Some of the top holdings include Pharmasset, Amgen, and Alexion Pharmaceutical.

BIS - UltraShort NASDAQ Biotechnology ETF

Like BIB, this fund also targets the NASDAQ Biotechnology Index and it also seeks a 2x leveraged daily return. However, BIS seeks and inverse return as well. As the underlying index goes down, the value of BIS goes up.

FBT - First Trust NYSE Arca Biotech Index ETF

This ETF tracks the NYSE Arca Biotechnology Index and some of the top holdings include Biogen (BIIB), Qiagen (QGEN), and Illumina (ILMN).

IBB - iShares Nasdaq Biotechnology ETF

Like BIB and BIS, this ETF also tracks the NASDAQ Biotechnology Index but seeks a single direct correlation as opposed to the others, not a leveraged or inverse return.

PBE - Invesco Dynamic Biotech Biotechnology & Genome ETF

This ETF tracks the Dynamic Biotechnology & Genome Intellidex Index and some of the top holdings include Biogen, Alexion, and Gilead Sciences.

XBI - SPDR S&P Biotech ETF

This SPDR tracks the S&P Biotechnology Select Industry Index and some of the top holdings include Pharmasset, Spectrum Pharmaceuticals, and Biogen

New Biotech ETFs

  • BBC - BioShares Biotechnology Clinical Trials Fund
  • BBP - BioShares Biotechnology Products Fund
  • LABS - Direxion Daily S & P Biotech Bear 1X Shares ETF
  • LABD - Direxion Daily S&P Biotech Bear 3X Shares ETF
  • LABU - Direxion Daily S&P Biotech Bull 3X Shares ETF
  • UBIO - UltraPro Nasdaq Biotechnology ETF
  • ZBIO - UltraPro Short Nasdaq Biotechnology ETF

Before making any trades, make sure to conduct your due diligence and research every ETF. Always be aware of the ins and outs of each fund and watch how they react to different market conditions. If you have any questions, don’t hesitate to consult your broker or a certified financial professional. Every trade has a risk, make sure you are well aware of yours.

The Balance does not provide tax, investment, or financial services and advice. The information is being presented without consideration of the investment objectives, risk tolerance, or financial circumstances of any specific investor and might not be suitable for all investors. Past performance is not indicative of future results. Investing involves risk including the possible loss of principal.